VITALANT - REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2

PIID: 75N92021F00001

Signed Date: Mar 31, 2021Effective Date: Apr 1, 2021End Date: Closed on Mar 31, 2025

Award $

$4.9M

Vendor

VITALANT

NAICS

541715

Signed Date

Mar 31, 2021

Key Details

Dollars Obligated

$4.9M

Base & All Options

$4.9M

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Parent IDIQ (PIID)

75N92019D00033

Product Service Code

AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

BETHESDA, MD

REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2

On Mar 31, 2021, Department of Health and Human Services obligated $4,906,930.06 to VITALANT for reds-iv-p center for transfusion laboratory studies (ctls) phase 2. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: full and open competition. Performance is located in BETHESDA, MD. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.